Tech Company Financing Transactions

Clementia Pharmaceuticals Funding Round

On 1/5/2015, Clementia Pharmaceuticals landed $10 million in Series A funding from OrbiMed and BDC Venture Capital.

Transaction Overview

Announced On
1/5/2015
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Series A
Investors

OrbiMed (Lead Investor) (David Bonita)

BDC Venture Capital (Jean-Francois Pariseau)

Proceeds Purpose
Proceeds will be used to support development of the company's lead compound palovarotene for the treatment of fibrodysplasia ossificans progressive (FOP).

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
4150 Ste-Catherine St. West 550
Montreal QC, H3Z 2Y5
Canada
Email Address
Not Recorded
Overview
Clementia Pharmaceuticals is focused on developing palovarotene for fibrodysplasia ossificans progressiva (FOP) and other diseases.
Profile
Clementia Pharmaceuticals LinkedIn Company Profile
Social Media
Clementia Pharmaceuticals Company Twitter Account
Company News
Clementia Pharmaceuticals News
Facebook
Clementia Pharmaceuticals on Facebook
YouTube
Clementia Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Clarissa Desjardins
  Clarissa Desjardins LinkedIn Profile  Clarissa Desjardins Twitter Account  Clarissa Desjardins News  Clarissa Desjardins on Facebook
Chief Financial Officer
Michael Singer
  Michael Singer LinkedIn Profile  Michael Singer Twitter Account  Michael Singer News  Michael Singer on Facebook
Chief Medical Officer
Donna Grogan
  Donna Grogan LinkedIn Profile  Donna Grogan Twitter Account  Donna Grogan News  Donna Grogan on Facebook
VP - Bus. Development
Jeffrey Packman
  Jeffrey Packman LinkedIn Profile  Jeffrey Packman Twitter Account  Jeffrey Packman News  Jeffrey Packman on Facebook
VP - Sales
Eric Grinstead
  Eric Grinstead LinkedIn Profile  Eric Grinstead Twitter Account  Eric Grinstead News  Eric Grinstead on Facebook


 

 

Browse more venture capital transactions:

Prev: 1/5/2015: Depict venture capital transaction
Next: 1/6/2015: Solarflare Communications venture capital transaction

 

Share this article

 


About Our VC Transactions Data

Our team works diligently to report on tech company VC transactions. VC transactions reported here are sourced from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary